Effects of vasodilators guanethidine, nicardipine, nitroglycerin, and prostaglandin E1 on primary afferent nociceptors in humans

Journal of Clinical Pharmacology

Volumn 37, Issue 4, 1997, Pages 330-335

  Mashimo, Takashi ^a   Pak, Myon ^a   Choe, Huhu ^a   Inagaki, Yoshimi ^a   Yamamoto, Mitsuaki ^b   Yoshiya, Ikuto ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; GUANETHIDINE; LIDOCAINE; NICARDIPINE; PROSTAGLANDIN E1; SODIUM CHLORIDE; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INTRADERMAL DRUG ADMINISTRATION; MALE; NOCICEPTIVE RECEPTOR; NORMAL HUMAN; PAIN THRESHOLD; SKIN BLOOD FLOW; SKIN TEMPERATURE; THERMAL EXPOSURE;

EID: 0030946264     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04310.x     Document Type: Article

References (38)

1. Devor M: Nerve pathophysiology and mechanisms of pain in causalgia. J Auton Nerv Syst 1983; 7:371-384.
2. Roberts W: A hypothesis on the physiological basis for causalgia and related pains. Pain 1986; 24:297-311.
3. Raja SN, Davis KD, Campbell JN: The adrenergic pharmacology of sympathetic maintained pain. J Reconstr Microsurg 1992; 8:63-69.
4. Bonica JJ: Causalgia and other reflex sympathetic dystrophies. In, Bonica JJ (ed.): The Management of Pain. Philadelphia: Lea & Febiger, 1990; 220-243.
5. Blumberg H, Jänig W: Clinical manifestations of reflex sympathetic dystrophy and sympathetically maintained pain. In, Wall PD, Melzack R (eds.): Textbook of Pain. London: Churchill Livingstone, 1994; 685-698.
6. Drummond PD, Finch PM, Smythe GA: Reflex sympathetic dystrophy: the significance of differing plasma cathecholamine concentrations in affected and unaffected limbs. Brain 1991; 114:2025-2036.
7. Raja SN, Choi Y, Asano Y, Holmes C, Goldstein DS: Arteriovenous differences in plasma concentrations of catechols in rats with neuropathic pain. Anesthesiology 1995; 83:1000-1008.
8. Cline MA, Ochoa J, Torebjörk HE: Chronic hyperalgesia and skin warming caused by sensitized C nociceptors. Brain 1989; 112:621-647.
9. Koltzenburg M, Torebjörk HE, Wahren LK: Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 1994; 117:579-591.
10. Scadding JW: Development of ongoing activity, mechanosensitivity, and adrenaline sensitivity in severed peripheral nerve axons. Exp Neurol 1981; 73:345-364.
11. Tanelian DL, Maclver MB: Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991; 74:934-936.
12. Hannington-Kiff JG: Intravenous sympathetic blockade with guanethidine. Lancet 1974; 1:1019-1029.
13. Chuinard RG, Dabezies EJ, Gould JS, Murphy GA, Matthews RE: Intravenous reserpine for treatment of reflex sympathetic dystrophy. Southern Med J 1981; 74:1481-1484.
14. Ghostine SY, Comair YG, Turnner DM, Kassel NF, Azar CG: Phenoxybenzamine in the treatment of causalgia. Report of 40 cases. J Neurosurg 1984; 60:1263-1268.
15. Raja SN, Treede R-D, Davis KD, Campbell JN: Systemic alpha-adrenergic blockade with phentolamine: A diagnostic test for sympathetically maintained pain. Anesthesiology 1991; 74:691-698.
16. Prough DS, McLeskey CH, Poehling GG, Koman LA, Weeks DB, Whitworth T, Semble EL: Efficacy of oral nifedipine in the treatment of reflex sympathetic dystrophy. Anesthesiology 1985; 62:796-799.
17. Mashimo T, Pak M, Inagaki Y, Yoshiya I: Effects of intravenous regional administration of vasodilators; guanethidine, nicardipine, nitroglycerine and prostaglandin E, in a patient with causalgia. The Pain Clinic 1995; 8:255-261.
18. 1 ointment. Anesth Analg 1991; 72:700-701.
19. Ferreira SH: Prostaglandins, aspirin-like drugs and analgesia. Nature New Biol 1972;240:200-203.
20. Ferreira SH, Moncada S. Vane JR: Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol 1973; 49:86-97.
21. 1 on rat cutaneous nerve activity. Br J Pharmacol 1977; 59:343-347.
22. Bonner RF, Clem TR, Bowen PD, Bowman RL: Laser-Doppler continuous real-time monitor of pulsatile and mean blood flow in tissue microcirculation. In, Chen S-H, Chu B, Nossal R (eds.): Scattering Technique Applied to Supramolecular and Nonequilibrium Systems. New York: Plenum Press, 1981; 685-701.
23. Watkins D, Holloway GA Jr: An instrument to measure cutaneous blood flow using the Doppler shift of laser light. IEEE Trans Biomed Eng 1978; 25:28-33.
24. Stern MD: In vivo evaluation of microcirculation by coherent light scattering. Nature 1975; 254:56-58.
25. Stern MD, Lappe DL, Bowen PD, Chimosky JE, Holloway GA Jr, Keiser HR, Bowman RL: Continuous measurement of tissue blood flow by laser-Doppler spectroscopy. Am J Physiol 1977; 232:441-448.
26. Nakahama H, Yamamoto M: An improved radiant heat algometer and its application to pain threshold measurements in man. Pain 1979; 6:141-148.
27. Meyer RA, Campbell JN, Raja SN: Peripheral neural mechanisms of nociception. In, Wall PD, Melzack R (eds.): Textbook of Pain. London: Churchill Livingstone, 1994; 13-41.
28. LaMotte RH, Campbell JN: Comparison of responses of warm and nociceptive C-fiber afferents in monkey with human judgments of thermal pain. J Neurophysiol 1978; 41:509-528.
29. Song CW, Chelstrom LM, Levitt SH, Haumschild DJ: Effects of temperature on blood circulation measured with the laser-Doppler method. Int J Rad Oncol Biol Phys 1989; 17:1041-1047.
30. Levine JD, Taiwo YO, Collins SD, Tam JK: Noradrenaline hyperalgesia is mediated through interaction with sympathetic post-ganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 1986; 323:158-160.
31. Gonzales R, Goldyne ME, Taiwo YO, Levine JD: Production of hyperalgesic prostaglandins by sympathetic postganglionic neurons. J Neurochem 1989; 53:1595-1598.
32. Schmidt WK, Way EL: Hyperalgesic effects of divalent cations and antinociceptive effects of a calcium chelator in native and morphine-dependent mice. J Pharmacol Exp Ther 1980; 212:22-27.
33. Benedek G, Sziksza M: Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol Res Comm 1984; 16:1009-1018.
34. Juan H, Seemann S: Selective reduction by some vasodilators and the prostaglandin antagonist SC-19220 of a response to the algesic effect of bradykinin. Eur J Pharmacol 1980; 65:267-278.
35. Feelisch M, Noack EA: Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139:19-30.
36. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH: Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1991; 7:615-624.
37. Meller ST, Gebhart GF: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52:127-136.
38. Shibuta S, Mashimo T, Ohara A, Zhang P, Yoshiya I: Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Nearosci Lett 1995; 187:103-106.